1. Home
  2. NVCR vs TDUP Comparison

NVCR vs TDUP Comparison

Compare NVCR & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • TDUP
  • Stock Information
  • Founded
  • NVCR 2000
  • TDUP 2009
  • Country
  • NVCR Switzerland
  • TDUP United States
  • Employees
  • NVCR N/A
  • TDUP N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • TDUP Catalog/Specialty Distribution
  • Sector
  • NVCR Health Care
  • TDUP Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • TDUP Nasdaq
  • Market Cap
  • NVCR 1.3B
  • TDUP 1.3B
  • IPO Year
  • NVCR 2015
  • TDUP 2021
  • Fundamental
  • Price
  • NVCR $11.25
  • TDUP $7.37
  • Analyst Decision
  • NVCR Buy
  • TDUP Buy
  • Analyst Count
  • NVCR 7
  • TDUP 3
  • Target Price
  • NVCR $28.64
  • TDUP $12.50
  • AVG Volume (30 Days)
  • NVCR 1.5M
  • TDUP 1.9M
  • Earning Date
  • NVCR 10-30-2025
  • TDUP 11-03-2025
  • Dividend Yield
  • NVCR N/A
  • TDUP N/A
  • EPS Growth
  • NVCR N/A
  • TDUP N/A
  • EPS
  • NVCR N/A
  • TDUP N/A
  • Revenue
  • NVCR $642,269,000.00
  • TDUP $298,376,000.00
  • Revenue This Year
  • NVCR $9.54
  • TDUP $18.15
  • Revenue Next Year
  • NVCR $5.70
  • TDUP $9.93
  • P/E Ratio
  • NVCR N/A
  • TDUP N/A
  • Revenue Growth
  • NVCR 11.17
  • TDUP 41.65
  • 52 Week Low
  • NVCR $10.70
  • TDUP $0.93
  • 52 Week High
  • NVCR $34.13
  • TDUP $12.28
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 35.05
  • TDUP 31.88
  • Support Level
  • NVCR $10.70
  • TDUP $7.54
  • Resistance Level
  • NVCR $12.01
  • TDUP $8.46
  • Average True Range (ATR)
  • NVCR 0.57
  • TDUP 0.58
  • MACD
  • NVCR -0.11
  • TDUP -0.07
  • Stochastic Oscillator
  • NVCR 15.48
  • TDUP 2.86

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About TDUP ThredUp Inc.

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.

Share on Social Networks: